INOZYME PHARMA INC. - COMMON STOCK

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference

08 May 2024 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights

07 May 2024 08:30:44 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 May 2024 08:30:02 By Nasdaq GlobeNewswire

Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency

08 Apr 2024 06:30:35 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Apr 2024 18:00:00 By Nasdaq GlobeNewswire

Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference

02 Apr 2024 08:30:03 By Nasdaq GlobeNewswire

Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024

26 Mar 2024 08:30:42 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights

12 Mar 2024 08:30:16 By Nasdaq GlobeNewswire

Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference

26 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Feb 2024 08:30:48 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Dec 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma to Participate in Upcoming Investor Conferences

09 Nov 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

07 Nov 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Nov 2023 16:15:00 By Nasdaq GlobeNewswire

Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023

26 Oct 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions

10 Oct 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting

06 Oct 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)

26 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023

20 Sep 2023 08:30:00 By Nasdaq GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Sep 2023 08:30:00 By Nasdaq GlobeNewswire